Literature DB >> 10631996

Human liver mitochondrial aldehyde dehydrogenase: three-dimensional structure and the restoration of solubility and activity of chimeric forms.

L Ni1, J Zhou, T D Hurley, H Weiner.   

Abstract

Human liver cytosolic and mitochondrial isozymes of aldehyde dehydrogenase share 70% sequence identity. However, the first 21 residues are not conserved between the human isozymes (15% identity). The three-dimensional structures of the beef mitochondrial and sheep cytosolic forms have virtually identical three-dimensional structures. Here, we solved the structure of the human mitochondrial enzyme and found it to be identical to the beef enzyme. The first 21 residues are found on the surface of the enzyme and make no contact with other subunits in the tetramer. A pair of chimeric enzymes between the human isozymes was made. Each chimera had the first 21 residues from one isozyme and the remaining 479 from the other. When the first 21 residues were from the mitochondrial isozyme, an enzyme with cytosolic-like properties was produced. The other was expressed but was insoluble. It was possible to restore solubility and activity to the chimera that had the first 21 cytosolic residues fused to the mitochondrial ones by making point mutations to residues at the N-terminal end. When residue 19 was changed from tyrosine to a cysteine, the residue found in the mitochondrial form, an active enzyme could be made though the Km for NAD+ was 35 times higher than the native mitochondrial isozyme and the specific activity was reduced by 75%. This residue interacts with residue 203, a nonconserved, nonactive site residue. A mutation of residue 18, which also interacts with 203, restored solubility, but not activity. Mutation to residue 15, which interacts with 104, also restored solubility but not activity. It appears that to have a soluble or active enzyme a favorable interaction must occur between a residue in a surface loop and a residue elsewhere in the molecule even though neither make contact with the active site region of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631996      PMCID: PMC2144226          DOI: 10.1110/ps.8.12.2784

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Crystallographic refinement by simulated annealing. Application to a 2.8 A resolution structure of aspartate aminotransferase.

Authors:  A T Brünger
Journal:  J Mol Biol       Date:  1988-10-05       Impact factor: 5.469

2.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

3.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Precise gene fusion by PCR.

Authors:  J Yon; M Fried
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

5.  Sequence of the precursor of bovine liver mitochondrial aldehyde dehydrogenase as determined from its cDNA, its gene, and its functionality.

Authors:  K L Guan; H Weiner
Journal:  Arch Biochem Biophys       Date:  1990-03       Impact factor: 4.013

6.  Mitochondrial aldehyde dehydrogenase from human liver. Primary structure, differences in relation to the cytosolic enzyme, and functional correlations.

Authors:  J Hempel; R Kaiser; H Jörnvall
Journal:  Eur J Biochem       Date:  1985-11-15

7.  Mitochondrial aldehyde dehydrogenase from horse liver. Correlations of the same species variants for both the cytosolic and the mitochondrial forms of an enzyme.

Authors:  J Johansson; H von Bahr-Lindström; R Jeck; C Woenckhaus; H Jörnvall
Journal:  Eur J Biochem       Date:  1988-03-15

8.  The structure of retinal dehydrogenase type II at 2.7 A resolution: implications for retinal specificity.

Authors:  A L Lamb; M E Newcomer
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

9.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  30 in total

1.  A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.

Authors:  Fei Wang; Shumei Zhai; Xiaojun Liu; Liwen Li; Shirley Wu; Q Ping Dou; Bing Yan
Journal:  Cancer Lett       Date:  2010-10-29       Impact factor: 8.679

2.  Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver.

Authors:  Kwan-Hoon Moon; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  FEBS Lett       Date:  2007-07-25       Impact factor: 4.124

3.  Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant.

Authors:  Heather N Larson; Henry Weiner; Thomas D Hurley
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

4.  Structure and biochemistry of phenylacetaldehyde dehydrogenase from the Pseudomonas putida S12 styrene catabolic pathway.

Authors:  Anders G Crabo; Baljit Singh; Tim Nguyen; Shahram Emami; George T Gassner; Matthew H Sazinsky
Journal:  Arch Biochem Biophys       Date:  2017-01-31       Impact factor: 4.013

5.  Crystal structure of lactaldehyde dehydrogenase from Escherichia coli and inferences regarding substrate and cofactor specificity.

Authors:  Luigi Di Costanzo; German A Gomez; David W Christianson
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

6.  Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.

Authors:  Cynthia A Morgan; Thomas D Hurley
Journal:  J Med Chem       Date:  2015-02-10       Impact factor: 7.446

Review 7.  Enzymes and signal pathways in the pathogenesis of alcoholic cardiomyopathy.

Authors:  E Leibing; T Meyer
Journal:  Herz       Date:  2016-09       Impact factor: 1.443

8.  Isolation and characterization of an aldehyde dehydrogenase encoded by the aldB gene of Escherichia coli.

Authors:  Kwok Ki Ho; Henry Weiner
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

9.  Molecular characterization of a thermostable aldehyde dehydrogenase (ALDH) from the hyperthermophilic archaeon Sulfolobus tokodaii strain 7.

Authors:  Tianming Liu; Lujiang Hao; Ruiming Wang; Bo Liu
Journal:  Extremophiles       Date:  2012-12-06       Impact factor: 2.395

10.  Analysis of nucleoside-binding proteins by ligand-specific elution from dye resin: application to Mycobacterium tuberculosis aldehyde dehydrogenases.

Authors:  Chang-Yub Kim; Cecelia Webster; Justin K M Roberts; Jin Ho Moon; Emily Z Alipio Lyon; Heungbok Kim; Minmin Yu; Li-Wei Hung; Thomas C Terwilliger
Journal:  J Struct Funct Genomics       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.